0001085037-18-000101.txt : 20180928 0001085037-18-000101.hdr.sgml : 20180928 20180928172810 ACCESSION NUMBER: 0001085037-18-000101 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180928 DATE AS OF CHANGE: 20180928 EFFECTIVENESS DATE: 20180928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BEVCANNA ENTERPRISES INC. CENTRAL INDEX KEY: 0001754180 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-322451 FILM NUMBER: 181095096 BUSINESS ADDRESS: STREET 1: 1672 WEST 2ND AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6J 1H4 BUSINESS PHONE: 6045691414 MAIL ADDRESS: STREET 1: 1672 WEST 2ND AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6J 1H4 D 1 primary_doc.xml X0708 D LIVE 0001754180 BEVCANNA ENTERPRISES INC. 1672 WEST 2ND AVENUE VANCOUVER A1 BRITISH COLUMBIA, CANADA V6J 1H4 6045691414 BRITISH COLUMBIA, CANADA NUTRIVIDA BIOTECH INVESTMENTS INC. None Corporation true 2017 Leone Marcello 1672 West 2nd Avenue Vancouver A1 BRITISH COLUMBIA, CANADA V6J 1H4 Executive Officer Director Chairman John Campbell 1672 West 2nd Avenue Vancouver A1 BRITISH COLUMBIA, CANADA V6J 1H4 Executive Officer Director Chief Financial Officer Martino Ciambrelli 1672 West 2nd Avenue Vancouver A1 BRITISH COLUMBIA, CANADA V6J 1H4 Executive Officer President Other Decline to Disclose 06b false 2018-09-13 false true false Business combination (RTO of target co by Issuer) whereby the Issuer's wholly owned subsidiary completed an amalgamation with target co resulting in Issuer's subsidiary acquiring shares of target co and the Issuer issuing shares in a 1:1 exchange. 0 63965 63965 0 $63,965.71 USD based on $49,215.75 CAD, the total proceeds from 196,863 Class B common shares, converted using Bank of Canada exchange rate of $0.7694 on September 13, 2018. false 2 0 0 0 false BEVCANNA ENTERPRISES INC. /s/ Martino Ciambrelli Martino Ciambrelli President 2018-09-28